LifePort Kidney Transporter ישראל - עברית - Ministry of Health

lifeport kidney transporter

בפקס בע"מ - מומחה - שייך למח' השתלות

JONEXA ישראל - עברית - Ministry of Health

jonexa

genzyme corporation - רופא - temporary replacement and supplement of synovial fluid

SEPRAFILM ישראל - עברית - Ministry of Health

seprafilm

genzyme corporation - רופא - an adjunct in abdominal, pelvic, and thoracic surgery for reducing the incidence, extent and severity of postoperative adhesions at the site of placement, and to reduce adhesive small bowel obstruction when placed in the abdomen.

אונג'נטיס 50 מג ישראל - עברית - Ministry of Health

אונג'נטיס 50 מג

truemed ltd, israel - opicapone - קפסולה קשיחה - opicapone 50 mg - opicapone

זביניקס 200 מג ישראל - עברית - Ministry of Health

זביניקס 200 מג

truemed ltd, israel - eslicarbazepine acetate - טבליה - eslicarbazepine acetate 200 mg - eslicarbazepine

זביניקס 800 מג ישראל - עברית - Ministry of Health

זביניקס 800 מג

truemed ltd, israel - eslicarbazepine acetate - טבליה - eslicarbazepine acetate 800 mg - eslicarbazepine

קימריה ישראל - עברית - Ministry of Health

קימריה

novartis israel ltd - tisagenlecleucel - tisagenlecleucel

לוטמקס תרחיף ישראל - עברית - Ministry of Health

לוטמקס תרחיף

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po

זפוסיה 0.23 מג ישראל - עברית - Ministry of Health

זפוסיה 0.23 מג

bristol, myers squibb (israel) limited, israel - ozanimod as hydrochloride - קפסולות - ozanimod as hydrochloride 0.23 mg - ozanimod